Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virus

Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virus

US Patent 8957199 · Granted Feb 17, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition for inhibiting replication of hepatitis B virus2025
Dengue virus vaccine2025
Electrodes for electroporation2022
Nasal hepatitis B vaccine composition and method for producing same2022
Urokinase-type plasminogen activator transgenic mouse2021
Hemagglutinin-binding peptide2020
Hemagglutinin-binding peptide2019
Prevention or treatment agent for hepatic fibrosis2019
Pharmaceutical composition for treatment and/or prevention of hepatitis C2018
Urokinase-type plasminogen activator transgenic mouse2018
Prevention or treatment agent for hepatic fibrosis2017
Recombinant vaccinia virus having hepatitis C virus gene2015